
Pillar Biosciences
Developer of a next-generation sequencing platform designed to support treatment selection through accurate testing across different stages of cancer care. The company offers proprietary technologies,...
Valuation
$309M
Latest known
Share Price
N/A
Total Raised
$120.9M
Last Round
N/A